Chong Chyn Chua

16PUBLICATIONS
59CO-AUTHORS
Haematological tumoursGene and molecular therapyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 01, 2024
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Ing Soo Tiong, Devendra K Hiwase, Emad Abro

|Dec 15, 2022
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells.

Charis E Teh, Hongke Peng, Meng-Xiao Luo

Pageof 3